Matt Goldman | CureTalks
Matt Goldman was diagnosed with multiple myeloma in May 2011 at the age of 49. He has had two relapses and has been on 5 different lines of treatment. Matt started on immunotherapy following a relapse and has been on the same regimen since then. Matt is currently in complete response but must continue with his regimen of a monthly immunotherapy infusion, a daily oral chemo and steroids. Matt had his stem cells collected in December 2011 but has no plans to undergo a stem cell transplant. Matt’s kidneys were damaged by the myeloma, but a combination of exercise and nutrition, along with stable myeloma have helped to keep his kidneys functioning. Matt worked full time from diagnosis until July 2017 when he decided to retire to focus on his health, family, and to rebuild his energy and strength. Matt lives in Long Beach, CA with his wife Leslie. He has a blog that documents his journey, www.mattvsmyeloma.com and is also on twitter at @mpg61.
Related Talks
CRISPR-edited Immune Cells Enhance Fight Against Blood Cancers
The Nobel prize winning CRISPR-Cas9 genome editing system is being explored for its potential use in cancer research and treatment. By deleting, inactivating,…
Understanding mRNA Covid-19 Vaccines
Messenger RNA vaccines, also called mRNA vaccines, are some of the first COVID-19 vaccines authorized for use in the United States. mRNA vaccines…
Legal Aspects of Navigating through Cancer Diagnosis and Treatment
A cancer diagnosis is overwhelming and accompanied with high degrees of stress and confusion related to survival, current & future treatments, and managing…
ASCO 2019 Highlights: Advances in Multiple Myeloma
ASCO 2019 conluded on 4th June 2019 and we are excited about Multiple Myeloma updates from the largest gathering of oncologists, researchers and…
Latest Advances in Myeloma Treatment: ASCO and EHA 2018 Highlights
The treatment field of Multiple Myeloma continues to move forward as novel agents and treatment combinations expand. Whether you are standard risk patient…